Myron Rapkin
61Patents
12h-index
28Co-inventors
84Inventor score
Filing activity: Apr 20, 1972 → Oct 31, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4678757A | Device and method for whole blood separation and analysis | Emerging Cross-Sectional Technologies | 102 | Expired |
| US4160008A | Multilayered test device for determining the presence of a liquid sample component, and method of use | Emerging Cross-Sectional Technologies | 65 | Expired |
| US8658128B2 | System and method for diagnosis and treatment | Physics | 56 | Active |
| US9314473B2 | System and method for diagnosis and treatment | Physics | 39 | Active |
| US9114147B2 | System and method for diagnosis and treatment | Physics | 38 | Active |
| US9320747B1 | System and method for diagnosis and treatment | Physics | 29 | Active |
| US4301115A | Test device resistant to cross contamination between reactant areas and process for making it | Emerging Cross-Sectional Technologies | 24 | Expired |
| US9878138B2 | Drug device configured for wireless communication | Emerging Cross-Sectional Technologies | 23 | Active |
| US4318985A | Method and device for detecting glucose concentration | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5260195A | Nonaqueous polymeric reagent compositions and applications thereof | Emerging Cross-Sectional Technologies | 16 | Expired |
| US8986677B2 | Therapeutic compositions and methods | Human Necessities | 16 | Active |
| US9878139B2 | Drug device configured for wireless communication | Emerging Cross-Sectional Technologies | 12 | Active |
| US4193766A | Device and method for preparation of a control solution for ketone determination | Emerging Cross-Sectional Technologies | 11 | Expired |
| US10537586B2 | System and method for diagnosis and treatment | Physics | 9 | Active |
| US9005914B2 | Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method | Performing Operations; Transporting | 9 | Active |
| US9855284B2 | Pharmaceutical compositions and methods | Chemistry; Metallurgy | 9 | Active |
| US10238666B2 | Pharmaceutical compositions and methods | Chemistry; Metallurgy | 9 | Active |
| US9598459B2 | Pharmaceutical compositions and methods | Chemistry; Metallurgy | 9 | Active |
| US4260579A | Device and method for simulating bilirubin in urine | Emerging Cross-Sectional Technologies | 8 | Expired |
| US11040037B2 | Therapeutic agents and methods | Chemistry; Metallurgy | 8 | Active |
| US10517881B2 | Pharmaceutical compositions and methods | Chemistry; Metallurgy | 8 | Active |
| US10010703B2 | Drug device configured for wireless communication | Emerging Cross-Sectional Technologies | 8 | Active |
| US9636351B2 | System and method for diagnosis and treatment | Physics | 7 | Active |
| US11224599B2 | Therapeutic agents and methods | Chemistry; Metallurgy | 7 | Active |
| US7326383B2 | Reagent, apparatus and method for measuring cyanuric acid | Physics | 6 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.